Protective Effect of Hesperidin against Cyclophosphamide Hepatotoxicity in Rats
Authors: Amr A. Fouad, Waleed H. Albuali, Iyad Jresat
Abstract:
The protective effect of hesperidin was investigated in rats exposed to liver injury induced by a single intraperitoneal injection of cyclophosphamide (CYP) at a dose of 150 mg kg-1. Hesperidin treatment (100 mg kg-1/day, orally) was applied for seven days, starting five days before CYP administration. Hesperidin significantly decreased the CYP-induced elevations of serum alanine aminotransferase, and hepatic malondialdehyde and myeloperoxidase activity, significantly prevented the depletion of hepatic glutathione peroxidase activity resulted from CYP administration. Also, hesperidin ameliorated the CYP-induced liver tissue injury observed by histopathological examination. In addition, hesperidin decreased the CYP-induced expression of inducible nitric oxide synthase, tumor necrosis factor-α, cyclooxygenase-2, Fas ligand, and caspase-9 in liver tissue. It was concluded that hesperidin may represent a potential candidate to protect against CYP-induced hepatotoxicity.
Keywords: Cyclophosphamide, hesperidin, liver, rats.
Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1093910
Procedia APA BibTeX Chicago EndNote Harvard JSON MLA RIS XML ISO 690 PDF Downloads 2276References:
[1] P. Perini, M. Calabrese, L. Rinaldi, P. Gallo, "The safety profile of cyclophosphamide in multiple sclerosis therapy,” Expert. Opin. Drug Saf., vol. 6, pp. 183-190, 2007.
[2] M. Haubitz, "Acute and long-term toxicity of cyclophosphamide,” Transplantationsmedizin, vol. 19, pp. S26-S31, 2007.
[3] E. Selvakumar, C. Prahalathan, Y. Mythili, P. Varalakshmi, "Mitigation of oxidative stress in cyclophosphamide-challenged hepatic tissue by DL-alpha-lipoic acid,” Mol. Cell Biochem., vol. 272, pp. 179-185, 2005.
[4] S. Jnaneshwari, M. Hemshekhar, M.S. Santhosh, K. Sunitha, R. Thushara, C. Thirunavukkarasu, K. Kemparaju, K.S. Girish, "Crocin, a dietary colorant, mitigates cyclophosphamide-induced organ toxicity by modulating antioxidant status and inflammatory cytokines,” J. Pharm. Pharmacol., vol. 65, pp. 604-614, 2013.
[5] M. Zarei, T. Shivanandappa, "Amelioration of cyclophosphamide-induced hepatotoxicity by the root extract of Decalepis hamiltonii in mice,” Food Chem. Toxicol., vol. 57, pp. 179-184, 2013.
[6] S. Nafees, S.T. Ahmad, W. Arjumand, S. Rashid, N. Ali, S. Sultana, "Modulatory effects of gentisic acid against genotoxicity and hepatotoxicity induced bycyclophosphamide in Swiss albino mice,” J. Pharm. Pharmacol., vol. 64, pp. 259-267, 2012.
[7] B.D. Sahu, M. Kuncha, G.J. Sindhura, R. Sistla, "Hesperidin attenuates cisplatin-induced acute renal injury by decreasing oxidative stress, inflammation and DNA damage,” Phytomedicine, vol. 20, pp. 453-460, 2013.
[8] D.I. Hamdan, M.F. Mahmoud, M. Wink, A.M. El-Shazly, "Effect of hesperidin and neohesperidin from bittersweet orange (Citrus aurantium var. bigaradia) peel on indomethacin-induced peptic ulcers in rats,” Environ. Toxicol. Pharmacol., vol. 37, pp. 907-915, 2014.
[9] G. Kaur, N. Tirkey, K. Chopra, "Beneficial effect of hesperidin on lipopolysaccharide-induced hepatotoxicity,” Toxicology, vol. 226, pp. 152-160, 2006.
[10] L. Pari, K. Shagirtha, "Hesperetin protects against oxidative stress related hepatic dysfunction by cadmium in rats,” Exp. Toxicol. Pathol., vol. 64, pp. 513-520, 2012.
[11] S.T. Ahmad, W. Arjumand, S. Nafees, A. Seth, N. Ali, S. Rashid, S. Sultana, "Hesperidin alleviates acetaminophen induced toxicity in Wistar rats by abrogation of oxidative stress, apoptosis and inflammation,” Toxicol. Lett., vol. 208, pp. 149-161, 2012.
[12] Y.H. Yeh, Y.L. Hsieh, Y.T. Lee, "Effects of yam peel extract against carbon tetrachloride-induced hepatotoxicity in rats,” J. Agric. Food Chem., vol. 61, pp. 7387-7396, 2013.
[13] M. Chen, H. Gu, Y. Ye, B. Lin, L. Sun, W. Deng, J. Zhang, J. Liu, "Protective effects of hesperidin against oxidative stress of tert-butyl hydroperoxide in human hepatocytes,” Food Chem. Toxicol., vol. 48, pp. 2980-2987, 2010.
[14] A.A. El-Sheikh, R.A. Rifaai, "Peroxisome proliferator activator receptor (PPAR)-γ ligand, but not PPAR-α, ameliorates cyclophosphamide-induced oxidative stress and inflammation in rat liver,” PPAR Res., vol. 2014, pp. 626319, 2014.
[15] S.M. Morris, T.R. Billiar, "New insights into the regulation of inducible nitric oxide synthesis,” Am. J. Physiol., vol. 266, pp. E829-E839, 1994.
[16] R.M. Clancy, S.B. Abramson, "Nitric oxide: a novel mediator of inflammation,” Proc. Soc. Exp. Biol. Med., vol. 210, pp. 93-101, 1995.
[17] C. Acipayam, I. Bayram, K. Daglioglu, F. Doran, S. Yilmaz, G. Sezgin, B. Totan Ateş, A. Ozkan, A. Tanyeli, "The protective effect of hesperidin on methotrexate-induced intestinal epithelial damage in rats: an experimental study,” Med. Princ. Pract., vol. 23, pp. 45-52, 2014.
[18] G. Saiprasad, P. Chitra, R. Manikandan, G. Sudhandiran, "Hesperidin alleviates oxidative stress and downregulates the expressions of proliferative and inflammatory markers in azoxymethane-induced experimental colon carcinogenesis in mice,” Inflamm. Res., vol. 62, pp. 425-440, 2013.
[19] L. Xu, Z.L. Yang, P. Li, Y.Q. Zhou, "Modulating effect of hesperidin on experimental murine colitis induced by dextran sulfate sodium,” Phytomedicine, vol. 16, pp. 989-995, 2009.
[20] D.M. Wang, S.Q. Li, X.Y. Zhu, Y. Wang, W.L. Wu, X.J. Zhang, "Protective effects of hesperidin against amyloid-β (Aβ) induced neurotoxicity through the voltage dependent anion channel 1 (VDAC1)-mediated mitochondrial apoptotic pathway in PC12 cells,” Neurochem. Res., vol. 38, pp. 1034-1044, 2013.